Review rate has been a standard metric among CDI professionals for years, but the use of prioritization tools to the CDI workflow means that reviewing every case is no longer necessary or the appropriate metric to measure CDI success. Fran Jurcak, Chief Clinical Strategist at Iodine, and Nita Bruce, Senior Product Support Specialist at Iodine, will discuss how CDI teams can better measure productivity and program success beyond the historically utilized CDI metrics. You will also hear about new metrics that CDI specialists should start looking at that better assess success and productivity.
Learning Objectives: Understand the limitations of using standard review rates as a performance metric Identify the differences between outcome metrics and performance metrics Discuss new metrics that allow CDI leaders to better manage their programs
